SecBot SecBot
6-K ·Filed Apr 29, 2026

GLAXF

GSK plc
NEUTRAL
Impact 2/10
Horizonimmediate Processed6mo ago SEC0001654954-26-004056
Notable filing: 6-K
Actionable Insight • Neutral

These routine insider transactions are not material. Monitor GSK's upcoming quarterly earnings and pipeline updates for meaningful catalysts. No trading action warranted based on this filing.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d ⚠ clustered
GLAXF ▼ -6.54% at T+60d
NEUTRAL call -6.54% · α vs SPY -10.65% · entry $27.08 → $25.31
Entry = T+0 close
Apr 29, 2026
via day close
T+1d
-3.88%
call -3.88% · α -4.90%
$26.03
settled 6mo ago
T+5d
-7.64%
call -7.64% · α -10.75%
$25.01
settled 6mo ago
T+20d
-5.58%
call -5.58% · α -11.04%
$25.57
settled 5mo ago
T+60d
-6.54%
call -6.54% · α -10.65%
$25.31
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

GSK filed a Form 6-K reporting routine share transactions by two insiders: Independent Non-Executive Director Wendy Becker purchased 4,000 ordinary shares at £19.6291 each on April 29, 2026, and Chief People Officer Diana Conrad acquired 12.874 American Depositary Shares at $54.5854 each under the GSK pension plan on April 27, 2026. These are standard insider transactions with no material financial impact or strategic significance.

Key Facts

  • Wendy Becker, Independent Non-Executive Director, purchased 4,000 ordinary shares at £19.6291 per share on April 29, 2026.
  • Diana Conrad, Chief People Officer, acquired 12.874 American Depositary Shares at $54.5854 per share under the GSK pension plan on April 27, 2026.
  • Both transactions were executed on public exchanges (London Stock Exchange and New York Stock Exchange).
  • No other material information was disclosed in the filing.

Financial Impact

Insider purchases total approximately £78,516 (Becker) and $703 (Conrad) — negligible relative to GSK's market cap.

Risk Factors

  • No material risks identified from this filing.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
41% bullish (32 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-004056
Document: 0001654954-26-004056-index-headers.html0001654954-26-004056
Document: 0001654954-26-004056-index.html0001654954-26-004056
Document: 0001654954-26-004056.txt0001654954-26-004056
51 reports for GLAXF
Performance horizon
46% Hit rate @ T+5 6 of 13 directional calls Went positive at some point 7 of 13 best @ T+20▲ +9.49%Jun 9, 2026
Filters
Rows
Reports for GLAXF — sortable, filterable
TypeNow
Jun 10, 2026
19w ago
6-K
NEUTRAL ★ 1/10
$25.12 $25.25▲ +0.52%▼ −1.62%$26.12 (+3.98%)
Jun 9, 2026
20w ago
6-K
NEUTRAL ★ 1/10
$24.66 $25.50▲ +3.41%▲ +1.60%$26.12 (+5.92%)
Jun 9, 2026
20w ago
6-K
BULLISH ★ 7/10
$24.66 $25.50▲ +3.41%▲ +1.60%$26.12 (+5.92%)
Jun 1, 2026
21w ago
6-K
NEUTRAL ★ 1/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.12 (+7.71%)
Jun 1, 2026
21w ago
6-K
NEUTRAL ★ 2/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.12 (+7.71%)
May 28, 2026
21w ago
6-K
BULLISH ★ 7/10
$24.58 $24.66▲ +0.33%▲ +0.01%$26.12 (+6.27%)
May 27, 2026
21w ago
6-K
NEUTRAL ★ 1/10
$25.57 $23.94▼ −6.37%▼ −7.58%$26.12 (+2.15%)
May 26, 2026
22w ago
6-K
NEUTRAL ★ 1/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.12 (+2.43%)
May 26, 2026
22w ago
6-K
NEUTRAL ★ 2/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.12 (+2.43%)
May 22, 2026
22w ago
6-K
NEUTRAL ★ 2/10
$26.00 $24.25▼ −6.73%▼ −8.39%$26.12 (+0.46%)
Showing 10 of 51

US Market Status

Market Open — Closes in 48m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 29, 2026